Diagnostic pitfalls of drug-induced immune hemolytic anemia
et
06 nov. 2019
À propos de cet article
Catégorie d'article: Case Report
Publié en ligne: 06 nov. 2019
Pages: 80 - 84
DOI: https://doi.org/10.21307/immunohematology-2019-101
Mots clés
© 2014 A. Salama et al., published by Sciendo
Immune hemolytic anemia (IHA) is a rare complication of drug administration. However, its true incidence remains obscure, as there are a number of factors that may lead to misdiagnosis. The clinical and serologic pictures are variable, and there is a great deal of unawareness that certain drugs can cause IHA. Furthermore, serologic results can be easily misinterpreted, resulting in a wrong diagnosis.